Evidence map›Paper›PMID 41773942›Full record

ArticleGigaScience2026

Interactive analysis of single-cell trajectories in 3D space with Cell Journey.

Damian Panas, Marcin Tabaka

Abstract read
In one paragraph

Article in GigaScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Damian PanasInternational Centre for Translational Eye Research, Skierniewicka 10A, Warsaw 01-230, Poland.ORCID 0000-0003-2181-2414
Marcin TabakaInternational Centre for Translational Eye Research, Skierniewicka 10A, Warsaw 01-230, Poland.ORCID 0000-0002-6166-2820

Funding

European Regional Development Fund FENG.02.01-IP.05-T005/23European Union
6 · The paper itself

Abstract

The integration of high-throughput single-cell profiling technologies with RNA velocity analysis has enabled the reconstruction of dynamic cellular differentiation trajectories at unprecedented resolution. Despite these advances, current visualization techniques for RNA velocity are predominantly confined to 2-dimensional representations, typically employing arrows or streamlines. While effective for depicting simple cellular trajectories, these approaches are insufficient for capturing the complex topologies of multipartite cellular transitions. This limitation highlights the need for advanced 3-dimensional visualization tools that can more accurately convey the structure and dynamics of velocity-inferred transitions in single-cell data. Here, we present Cell Journey, an interactive visualization platform specifically developed for 3-dimensional analysis and representation of RNA velocity trajectories derived from single-cell datasets. The platform features an intuitive graphical interface supporting both unimodal and multimodal data, accommodates multiple input formats, and provides extensive customization capabilities for trajectory visualization. Cell Journey computes RNA velocity vector fields on a user-defined 3-dimensional grid and constructs velocity trajectories using either Euler integration or the fourth-order Runge-Kutta method. The platform enables dynamic exploration of cellular dynamics through interactive visual elements, including streamlines, streamlets, cones, and volumetric plots. Furthermore, it allows users to investigate changes in feature activity along selected paths, facilitating deeper insights into cellular state transitions within complex multimodal single-cell datasets.

Indexed as

Computational BiologyImaging, Three-DimensionalSingle-Cell AnalysisSoftwareHumansRNARNAdevelopmental trajectoryRNA velocitysingle-cell multiomics

Identifiers

PMID41773942
PMCPMC13042281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.